ZA201103575B - Methods for selecting protease resistant polypeptides - Google Patents
Methods for selecting protease resistant polypeptidesInfo
- Publication number
- ZA201103575B ZA201103575B ZA2011/03575A ZA201103575A ZA201103575B ZA 201103575 B ZA201103575 B ZA 201103575B ZA 2011/03575 A ZA2011/03575 A ZA 2011/03575A ZA 201103575 A ZA201103575 A ZA 201103575A ZA 201103575 B ZA201103575 B ZA 201103575B
- Authority
- ZA
- South Africa
- Prior art keywords
- methods
- protease resistant
- resistant polypeptides
- selecting protease
- selecting
- Prior art date
Links
- 108091005804 Peptidases Proteins 0.000 title 1
- 239000004365 Protease Substances 0.000 title 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
- G01N33/6857—Antibody fragments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Endocrinology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12013508P | 2008-12-05 | 2008-12-05 | |
| PCT/EP2009/066395 WO2010063818A2 (en) | 2008-12-05 | 2009-12-04 | Methods for selecting protease resistant polypeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201103575B true ZA201103575B (en) | 2012-01-25 |
Family
ID=42169477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2011/03575A ZA201103575B (en) | 2008-12-05 | 2011-05-16 | Methods for selecting protease resistant polypeptides |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US8685895B2 (enExample) |
| EP (1) | EP2364326B1 (enExample) |
| JP (2) | JP5840498B2 (enExample) |
| KR (1) | KR101740066B1 (enExample) |
| CN (1) | CN102307897B (enExample) |
| AU (1) | AU2009324037B2 (enExample) |
| BR (1) | BRPI0922772B1 (enExample) |
| CA (1) | CA2745448C (enExample) |
| EA (1) | EA026508B1 (enExample) |
| ES (1) | ES2688621T3 (enExample) |
| IL (1) | IL212923A0 (enExample) |
| MX (1) | MX2011005874A (enExample) |
| SG (1) | SG194383A1 (enExample) |
| WO (1) | WO2010063818A2 (enExample) |
| ZA (1) | ZA201103575B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA026508B1 (ru) * | 2008-12-05 | 2017-04-28 | Глэксо Груп Лимитед | Единичный вариабельный домен иммуноглобулина и выделенный устойчивый к протеазе полипептид, связывающие сывороточный альбумин человека |
| EP2603522A1 (en) * | 2010-08-13 | 2013-06-19 | GlaxoSmithKline Intellectual Property Development Limited | Improved anti-serum albumin binding variants |
| WO2012022703A2 (en) * | 2010-08-20 | 2012-02-23 | Glaxo Group Limited | Improved anti-serum albumin binding variants |
| JP6210982B2 (ja) * | 2012-06-22 | 2017-10-11 | オリンパス株式会社 | 膵液成分含有試料の調製方法、及び膵液成分を含有する生体試料の室温保存用キット |
| RU2016104651A (ru) * | 2013-07-15 | 2017-08-16 | Норт Каролайна Стейт Юниверсити | Устойчивые к протеазам пептидные лиганды |
| JP6422977B2 (ja) | 2013-08-30 | 2018-11-14 | エイプリルバイオ カンパニー リミテッド | 抗血清アルブミンｆａｂエフェクター部分融合コンストラクト、およびその製造方法 |
| CN115925961A (zh) * | 2015-05-28 | 2023-04-07 | 生物辐射实验室股份有限公司 | 亲和配体及其相关方法 |
| TWI726889B (zh) * | 2015-06-10 | 2021-05-11 | 英商梅迪繆思有限公司 | 蛋白酶抗性之脂化肽 |
| CN110506105B (zh) * | 2017-03-28 | 2023-03-24 | 森永乳业株式会社 | 新型双歧杆菌属细菌 |
| AU2020229349A1 (en) * | 2019-02-26 | 2021-10-14 | Twist Bioscience Corporation | Variant nucleic acid libraries for GLP1 receptor |
| US11584781B2 (en) * | 2019-12-30 | 2023-02-21 | Eligo Bioscience | Chimeric receptor binding proteins resistant to proteolytic degradation |
| KR20210095781A (ko) | 2020-01-24 | 2021-08-03 | 주식회사 에이프릴바이오 | 항원결합 단편 및 생리활성 이펙터 모이어티로 구성된 융합 컨스트럭트를 포함하는 다중결합항체 및 이를 포함하는 약학조성물 |
| EP4204460A4 (en) | 2020-08-26 | 2024-09-25 | Twist Bioscience Corporation | METHODS AND COMPOSITIONS RELATING TO GLP1R VARIANTS |
| US12122817B2 (en) * | 2020-09-22 | 2024-10-22 | Serpentide Inc. | Long-lasting GLP1 analogue drug for type-2 diabetes |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8725529D0 (en) | 1987-10-30 | 1987-12-02 | Delta Biotechnology Ltd | Polypeptides |
| JP3095168B2 (ja) | 1988-02-05 | 2000-10-03 | エル． モリソン，シェリー | ドメイン‐変性不変部を有する抗体 |
| EP0436597B1 (en) | 1988-09-02 | 1997-04-02 | Protein Engineering Corporation | Generation and selection of recombinant varied binding proteins |
| ATE92107T1 (de) | 1989-04-29 | 1993-08-15 | Delta Biotechnology Ltd | N-terminale fragmente von menschliches serumalbumin enthaltenden fusionsproteinen. |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5977307A (en) | 1989-09-07 | 1999-11-02 | Alkermes, Inc. | Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US6172197B1 (en) | 1991-07-10 | 2001-01-09 | Medical Research Council | Methods for producing members of specific binding pairs |
| JP2938569B2 (ja) | 1990-08-29 | 1999-08-23 | ジェンファーム インターナショナル，インコーポレイティド | 異種免疫グロブリンを作る方法及びトランスジェニックマウス |
| EP0562025B1 (en) | 1990-12-06 | 2001-02-07 | Affymetrix, Inc. (a Delaware Corporation) | Compounds and their use in a binary synthesis strategy |
| WO1993011236A1 (en) | 1991-12-02 | 1993-06-10 | Medical Research Council | Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| US5733743A (en) | 1992-03-24 | 1998-03-31 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| WO1994029351A2 (en) | 1993-06-16 | 1994-12-22 | Celltech Limited | Antibodies |
| US5702892A (en) | 1995-05-09 | 1997-12-30 | The United States Of America As Represented By The Department Of Health And Human Services | Phage-display of immunoglobulin heavy chain libraries |
| ES2176484T3 (es) | 1995-08-18 | 2002-12-01 | Morphosys Ag | Bancos de proteinas/(poli)peptidos. |
| WO1999002671A1 (en) | 1997-07-07 | 1999-01-21 | Medical Research Council | In vitro sorting method |
| GB9722131D0 (en) | 1997-10-20 | 1997-12-17 | Medical Res Council | Method |
| CA2328422A1 (en) | 1998-05-13 | 1999-11-18 | Diversys Limited | Selection system |
| IL127127A0 (en) | 1998-11-18 | 1999-09-22 | Peptor Ltd | Small functional units of antibody heavy chain variable regions |
| AU3040101A (en) | 2000-02-03 | 2001-08-14 | Domantis Limited | Combinatorial protein domains |
| MXPA03005036A (es) | 2000-12-07 | 2003-09-05 | Lilly Co Eli | Proteinas de fusion glp-1. |
| WO2002095076A2 (en) * | 2001-05-23 | 2002-11-28 | Kabushiki Kaisha Toyota Chuo Kenkyusho | Modified polypeptides having protease-resistance and/or protease-sensitivity |
| WO2003002136A2 (en) | 2001-06-28 | 2003-01-09 | Novo Nordisk A/S | Stable formulation of modified glp-1 |
| US20080108560A1 (en) | 2002-03-05 | 2008-05-08 | Eli Lilly And Company | Heterologous G-Csf Fusion Proteins |
| US7696320B2 (en) * | 2004-08-24 | 2010-04-13 | Domantis Limited | Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor |
| US9321832B2 (en) | 2002-06-28 | 2016-04-26 | Domantis Limited | Ligand |
| US20060002935A1 (en) | 2002-06-28 | 2006-01-05 | Domantis Limited | Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor |
| NZ540194A (en) | 2002-11-08 | 2008-07-31 | Ablynx Nv | Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| EP1594530A4 (en) | 2003-01-22 | 2006-10-11 | Human Genome Sciences Inc | HYBRID PROTEINS OF ALBUMIN |
| TW200526254A (en) | 2003-09-19 | 2005-08-16 | Novo Nordisk As | Novel GLP-1 derivatives |
| ATE479760T1 (de) | 2004-03-24 | 2010-09-15 | Domantis Ltd | Universelles signalpeptid gas1 |
| WO2006059106A2 (en) * | 2004-12-02 | 2006-06-08 | Domantis Limited | Bispecific domain antibodies targeting serum albumin and glp-1 or pyy |
| AU2007323035B2 (en) * | 2006-10-03 | 2011-11-24 | Cadila Healthcare Limited | Antidiabetic compounds |
| GB0724331D0 (en) * | 2007-12-13 | 2008-01-23 | Domantis Ltd | Compositions for pulmonary delivery |
| AU2009231439A1 (en) * | 2008-03-31 | 2009-10-08 | Glaxo Group Limited | Drug fusions and conjugates |
| EA026508B1 (ru) * | 2008-12-05 | 2017-04-28 | Глэксо Груп Лимитед | Единичный вариабельный домен иммуноглобулина и выделенный устойчивый к протеазе полипептид, связывающие сывороточный альбумин человека |
| UY32452A (es) * | 2009-02-19 | 2010-09-30 | Glaxo Group Ltd | Variantes de unión a anti-albúmina de suero mejoradas |
-
2009
- 2009-12-04 EA EA201170762A patent/EA026508B1/ru not_active IP Right Cessation
- 2009-12-04 JP JP2011539034A patent/JP5840498B2/ja active Active
- 2009-12-04 BR BRPI0922772-5A patent/BRPI0922772B1/pt active IP Right Grant
- 2009-12-04 EP EP09764259.9A patent/EP2364326B1/en active Active
- 2009-12-04 CA CA2745448A patent/CA2745448C/en active Active
- 2009-12-04 WO PCT/EP2009/066395 patent/WO2010063818A2/en not_active Ceased
- 2009-12-04 US US13/131,640 patent/US8685895B2/en active Active
- 2009-12-04 SG SG2013073069A patent/SG194383A1/en unknown
- 2009-12-04 ES ES09764259.9T patent/ES2688621T3/es active Active
- 2009-12-04 MX MX2011005874A patent/MX2011005874A/es not_active Application Discontinuation
- 2009-12-04 AU AU2009324037A patent/AU2009324037B2/en not_active Ceased
- 2009-12-04 KR KR1020117015383A patent/KR101740066B1/ko not_active Expired - Fee Related
- 2009-12-04 CN CN200980156194.1A patent/CN102307897B/zh active Active
-
2011
- 2011-05-16 ZA ZA2011/03575A patent/ZA201103575B/en unknown
- 2011-05-16 IL IL212923A patent/IL212923A0/en unknown
-
2014
- 2014-02-10 US US14/176,231 patent/US10466252B2/en active Active
-
2015
- 2015-07-24 JP JP2015147120A patent/JP2015231380A/ja active Pending
-
2017
- 2017-08-17 US US15/679,191 patent/US10302655B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2364326A2 (en) | 2011-09-14 |
| CA2745448A1 (en) | 2010-06-10 |
| AU2009324037B2 (en) | 2015-07-30 |
| US20140187750A1 (en) | 2014-07-03 |
| WO2010063818A3 (en) | 2010-08-12 |
| MX2011005874A (es) | 2011-06-27 |
| JP2015231380A (ja) | 2015-12-24 |
| CN102307897B (zh) | 2016-01-20 |
| EA026508B1 (ru) | 2017-04-28 |
| BRPI0922772A2 (en) | 2018-11-06 |
| KR101740066B1 (ko) | 2017-05-25 |
| BRPI0922772B1 (pt) | 2021-09-08 |
| EP2364326B1 (en) | 2018-07-04 |
| CA2745448C (en) | 2018-09-18 |
| CN102307897A (zh) | 2012-01-04 |
| WO2010063818A2 (en) | 2010-06-10 |
| JP2012510803A (ja) | 2012-05-17 |
| US10302655B2 (en) | 2019-05-28 |
| US10466252B2 (en) | 2019-11-05 |
| AU2009324037A1 (en) | 2010-06-10 |
| US20180088128A1 (en) | 2018-03-29 |
| JP5840498B2 (ja) | 2016-01-06 |
| ES2688621T3 (es) | 2018-11-05 |
| SG194383A1 (en) | 2013-11-29 |
| US20110229458A1 (en) | 2011-09-22 |
| IL212923A0 (en) | 2011-07-31 |
| US8685895B2 (en) | 2014-04-01 |
| EA201170762A1 (ru) | 2011-12-30 |
| KR20110102397A (ko) | 2011-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201103575B (en) | Methods for selecting protease resistant polypeptides | |
| GB0721686D0 (en) | Polypeptides | |
| IL213950A0 (en) | Transaminase polypeptides | |
| ZA200810738B (en) | Polypeptide | |
| ZA201000283B (en) | Reinigung pegylierter polypeptide | |
| GB0723712D0 (en) | Peptides | |
| EP2480578A4 (en) | MODIFICATION OF POLYPEPTIDE | |
| GB0920981D0 (en) | Peptides | |
| EP2123666A4 (en) | PEPTIDE | |
| ZA201108446B (en) | FViII-DERIVED PEPTIDES | |
| ZA201203722B (en) | Peptide | |
| GB0809659D0 (en) | Polypeptides | |
| GB0712302D0 (en) | Chrondroitinase polypeptides | |
| EP2136831A4 (en) | ANTI-ANGIOGENIC PEPTIDES | |
| GB0703945D0 (en) | Peptide | |
| GB0920987D0 (en) | Peptides | |
| GB0623539D0 (en) | Polypeptides | |
| IL197675A0 (en) | Peptides | |
| GB0817978D0 (en) | Peptides | |
| GB0804696D0 (en) | Detecting polypeptides | |
| GB0815673D0 (en) | Peptides | |
| GB0812093D0 (en) | Phylloseptin peptides | |
| GB0810449D0 (en) | Peptides | |
| GB0707626D0 (en) | Peptides | |
| GB0705251D0 (en) | Peptides |